相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FDG PET/CT in differentiated thyroid cancer patients with low thyroglobulin levels
Chantal A. Lebbink et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)
Current practice in patients with differentiated thyroid cancer
Martin Schlumberger et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
David L. Chan et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Multikinase inhibitors in thyroid cancer: timing of targeted therapy
Matti L. Gild et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Usefulness of PET/CT with 18F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study
Luca Filippi et al.
DIAGNOSTICS (2021)
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers
Lara A. Dunn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-Up
R. Michael Tuttle et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
FDG PET/CT for the early prediction of RAI therapy response in patients with metastatic differentiated thyroid carcinoma
Seo Young Kang et al.
PLOS ONE (2019)
Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol
Amir Iravani et al.
THYROID (2019)
Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer
Poorni M. Manohar et al.
CLINICAL NUCLEAR MEDICINE (2018)
Selective use of radioactive iodine (RAI) in thyroid cancer: No longer one size fits all
J. L. Marti et al.
EJSO (2018)
Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine
Tania Jaber et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance
David L. H. Chan et al.
THERANOSTICS (2017)
I-124 Imaging and Dosimetry
Russ Kuker et al.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY (2017)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Metastatic Differentiated Thyroid Cancers
Soizic Masson-Deshayes et al.
CLINICAL NUCLEAR MEDICINE (2015)
Prognostic Role of 18F-FDG PET/CT in the Postoperative Evaluation of Differentiated Thyroid Cancer Patients
Leonardo Pace et al.
CLINICAL NUCLEAR MEDICINE (2015)
FDG PET Performed at Thyroid Remnant Ablation Has a Higher Predictive Value for Long-Term Survival of High-Risk Patients With Well-Differentiated Thyroid Cancer Than Radioiodine Uptake
Florian C. Gaertner et al.
CLINICAL NUCLEAR MEDICINE (2015)
Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival
Charles Marcus et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2015)
Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib
S. Michael Rothenberg et al.
CLINICAL CANCER RESEARCH (2015)
Long-Term Survival and Low Effective Cumulative Radioiodine Doses to Achieve Remission in Patients With 131Iodine-Avid Lung Metastasis From Differentiated Thyroid Cancer
Fabian Pitoia et al.
CLINICAL NUCLEAR MEDICINE (2014)
Prognostic Factors Affecting Disease-Specific Survival in Patients with Recurrent and/or Metastatic Differentiated Thyroid Carcinoma Detected by Positron Emission Tomography/Computed Tomography
Burcu Esen Akkas et al.
THYROID (2014)
Definition and management of radioactive iodine-refractory differentiated thyroid cancer
Martin Schlumberger et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
Alan L. Ho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Distant metastatic lesions in patients with differentiated thyroid carcinoma Clinical implications of radioiodine and FDG uptake
C. M. Hong et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2013)
Response Criteria in Oncologic Imaging: Review of Traditional and New Criteria
Temel Tirkes et al.
RADIOGRAPHICS (2013)
PET/CT Imaging of Thyroid Cancer
Camila Mosci et al.
CLINICAL NUCLEAR MEDICINE (2011)
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
D. Deandreis et al.
ENDOCRINE-RELATED CANCER (2011)
Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning
RJ Robbins et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
分享论文
